Financial statements Apteka Echinacea
Balance sheet data of APTEKA ECHINACEA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|---|---|---|---|---|---|---|
Total assets | 171 803,67 | 528 880,68 | 538 475,34 | 546 755,18 | 652 038,51 | 655 528,14 | 668 903,26 |
A. Fixed assets | 43 759,21 | 153 400,53 | 123 389,49 | 98 290,69 | 69 365,47 | 47 204,05 | 39 003,93 |
B. Current assets | 128 044,46 | 375 480,15 | 415 085,85 | 448 464,49 | 582 673,04 | 608 324,09 | 629 899,33 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 171 803,67 | 528 880,68 | 538 475,34 | 546 755,18 | 652 038,51 | 655 528,14 | 668 903,26 |
A. Equity | 40 596,11 | -57 942,63 | 64 061,25 | 89 445,86 | 151 125,89 | 185 319,51 | 204 764,67 |
B. Liabilities and provisions for liabilities | 131 207,56 | 586 823,31 | 474 414,09 | 457 309,32 | 500 912,62 | 470 208,63 | 464 138,59 |
I. Long-term liabilities | 0,00 | 323 550,69 | 161 823,56 | 105 139,72 | 87 311,77 | 31 674,15 | 0,00 |
II. Short-term liabilities | 131 207,56 | 263 272,62 | 312 590,53 | 352 169,60 | 413 600,85 | 438 534,48 | 464 138,59 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.